ADB-5'Br-BUTINACAADB-5'Br-BUTINACA (ADB-B-5Br-INACA) is an indazole-3-carboxamide based synthetic cannabinoid receptor agonist which has been sold as a designer drug, first detected in Philadelphia in the US in May 2022, and subsequently found in South Korea, Portugal and Sweden. Read from the Drugbox of the Wikipedia article ADB-5'Br-BUTINACA, revision 1359974631.

Property

Value

Formula

C18H25BrN4O2, 409.33 g/mol

The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.